“EFFICACY OF NEWER GLP-1 RECEPTOR AGONISTS ON NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES”, RMSR, vol. 3, no. 5, pp. 290–294, May 2025, Accessed: Aug. 18, 2025. [Online]. Available: https://www.medscireview.net/index.php/Journal/article/view/1109